Advanced Biomed Inc. (NASDAQ:ADVB) Shares Shorted: Short Interest Down 39.8% in September

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a significant decrease in short interest in September. As of September 15th, there was short interest totaling 9,845 shares, a decrease of 39.8% from the August 31st total of 16,357 shares. Approximately 0.8% of the shares of the company are short sold. Based on an average daily volume of 110,241 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ADVB shares. Weiss Ratings upgraded shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 23rd. Wall Street Zen upgraded shares of Advanced Biomed to a “hold” rating in a research note on Saturday, August 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Advanced Biomed Price Performance

Advanced Biomed stock opened at $6.91 on Friday. The company has a market capitalization of $11.40 million, a PE ratio of 1.43 and a beta of 0.02. Advanced Biomed has a one year low of $3.61 and a one year high of $24.23. The business has a 50 day simple moving average of $8.53 and a 200 day simple moving average of $6.37.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.